Arizona State University and Dublin City University, Dublin, Ireland are joining forces to create the new International School of Biomedical Diagnostics, which will offer the first degree program of its kind.Continue reading
Author Archive: AZBio
AZBIA and Traklight to Host Educational Event for Local Arizona Entrepreneurs
Traklight LLC, a Phoenix-based provider of online software and tools that easily identify and secure intellectual property (IP), will team up with the Arizona Business Incubation Association (AzBIA) to host an educational event from 6 p.m. to 8 p.m. on January 15, 2014 at the Center for Entrepreneurial Innovation (CEI).
The purpose of the event is to set Arizona entrepreneurs up for success in 2014 by showcasing the resources available to entrepreneurs through the AzBIA. Organization members will provide guidance and share their success stories. Entrepreneurs also will learn how to identify, protect and leverage their intellectual property (IP). Traklight CEO Mary Juetten will discuss the importance of IP in the startup and entrepreneurial space, and patent, copyright and business attorneys will be on-hand to answer questions.
“The proper identification and protection of IP is critical to companies as they bring new high tech products to markets domestically and internationally,” said Russ Yelton. President AzBIA. “The AzBIA is proud to partner with Tracklight and offer these innovative tools to help incubating companies across the state better track and protect their intellectual property.”
“Tracklight is looking forward to partner with the AzBIA to help incubating companies better track and protect their intellectual property (IP),” said Jill HowardAllen, COO at Traklight.
To learn more about this free event or to RSVP, visit info.traklight.com/new-year.
About Traklight LLC
Traklight provides cost-effective online IP identification tools and resources that enable inventors, creators, entrepreneurs and small businesses to identify and protect their IP. Using a dynamic set of questions, users can identify the potential IP associated with their ideas. Next, users simply upload important information to the IP Vault, where the files are time-stamped, stored and protected. Traklight is privately held and headquartered in Arizona. Visit traklight.com to learn more and take the free Risk Quiz.
About AzBIA
The Arizona Business Incubation Association (AzBIA ) has 23 member organizations including incubators, co-work spaces and accelerators. The AzBIA’s goal is to strengthen Arizona’s entrepreneurial landscape by connecting programs and companies.
New Look Inside Cell Nucleus Could Improve Cancer Diagnostics
By Daniel Stolte, University Communications | December 21, 2013
OMB releases Federal Grant Reform Guidance developed by COFAR
As 2013 came to a close, on December 26, 2013, the Office of Management Budget (OMB) issued the long-awaited final rule to the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, more commonly known as the “Super Circular.” This rule finalizes OMB’s proposed guidance from February 1, 2013, and represents the culmination of an effort that was more than two years in the making. Among other things, this rule streamlines eight Federal regulations (including OMB Circulars A-110, A-122, and A-133) into a single, comprehensive policy guide and affords the Federal government the ability to better administer the $600 billion awarded annually for grants, cooperative agreements, and other types of financial assistance. This will have important implications for all nonprofit recipients of, and applicants for, Federal grants and cooperative agreements (“awards”). (Source and Super Circular summary: Venable, LLP)
(NSF Video: http://youtu.be/xBmjulDwDWk)
To assist organizations in understanding the final rule, OMB hosted an informational webcast on December 20, 2013 with team members from COFAR agencies. The recorded webcast is shown above. For more information visit www.cfo.gov/cofar.
To view the Super Circular, click here.
While effective December 26, 2013, actual roll out by agencies will continue throughout 2014. It will be imperative for nonprofit organizations to assess their current practices and policies and take appropriate steps to ensure that they conform with the final rule in a timely manner.
Amgen Romosozumab Phase 2 Data Published In New England Journal Of Medicine
AZBio Predictions for 2014
2013 will soon take its place in the history books with fireworks and strains of Auld Lang Syne.
As 2014 approaches, let’s look into our crystal ball for some predictions of what the new year may have in store…Continue reading
SynCardia raises $14M in December to Fund Rapid Growth
Privately held SynCardia Systems, Inc. announced, on December 17th, that it had raised $14 million to fund the rapid growth of the only approved medical device that eliminates the symptoms and source of end-stage heart failure, the SynCardia temporary Total Artificial Heart. The SynCardia Total Artificial Heart is the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart.Continue reading
UA College of Nursing and Banner Health Researchers Test Tool for Early Recognition of Devastating Disease Affecting Babies Born Pre-Term
UA Assistant Professor Sheila M. Gephart developed GutCheckNEC to help Neonatal Intensive Care Unit nurses identify babies at risk of developing necrotizing enterocolitis.Continue reading
Telemedicine is everybody’s business
Arizona Telemedicine Program is a Model ‘Telehealth Technology Innovation Accelerator’ for the Telemedicine Industry: A number of outstanding telemedicine programs, owned by different health-care organizations, work together on telemedicine challenges ranging from legal and regulatory issues, to telecommunications technology, to reimbursement.Continue reading
New clinical trial at BNI targets cancer metabolism
Metabolic dysregulation in tumors is a topic of intense interest in the study of cancer, and the therapeutic value of altering tumor metabolism is a new frontier in cancer research. Unlike genetic traits that may not be present in all cells of a patient’s tumor, one trait shared by virtually all tumor cells is altered metabolism.Continue reading